
Taproot Medical Technologies Profile last edited on: 8/21/20
CAGE: 7VAM4
UEI: UG6LYQZZKX33
Business Identifier: Biocompatible materials designed for use in medical device development. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 07
County: King
Congr. District: 07
County: King
Public Profile
Taproot Medical technologies is a biomaterial startup - somewhat in stealth mode - working on new types of biomedical materials having potential application areas of use in neuro-critical care, aesthetics, ophthalmology, and cellular therapies. With an asembled team of highly experienced players, the effort organizes around next-generation materials that are impervious to living organisms: compatible with biomolecules, cells and tissues
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2020 | 2 | NSF | $1,507,979 | |
Project Title: Development of Injectable, Enzyme-Degradable Poly(carboxybetaine) Hydrogel Formulations as Aesthetic and Surgical Tissue Fillers |
Key People / Management
Jens Quistgaard -- President and CEO
Shaoyi Jiang
Andrew Sinclair -- Senior Scientist
Shaoyi Jiang
Andrew Sinclair -- Senior Scientist